Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043931794> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2043931794 abstract "The receptor of thromboxane A2 (TXA2), TP, is a seven transmembrane, G-protein-coupled receptor. Increased expression of TP at RNA level was found to correlate with a poor prognosis in breast cancer patients but it is unknown how TP expression and activities are involved in breast cancer progression. Here we report that TP is expressed in metastatic breast cancer cells at both RNA and protein levels. Treatment of breast cancer MDA-MB-231 cells by U46619, a TP agonist, induced cell body contraction. The U46619-induced contraction was blocked by SQ29548, a high-affinity TP antagonist. Further studies found that small GTPase RhoA was activated by TP activation and that pretreatment of MDA-MB-231 cells with Y27632, a Rho kinase (ROCK) inhibitor, blocked U46619-induced cell contraction. The requirement of RhoA activation in U46619 induced cell contraction was further confirmed by the ability of dominant negative RhoA to block cell contraction induced by U46619. MDA-MB-231 cells with TP knockdown displayed a reduced percentage of contraction under the treatment of U46619 and TXA2 agonist I-BOP as well as attenuated invasion ability. When injected into mice, MDA-MB-231 cells with TP depleted did not present significant changes in primary tumor formation or growth. However, TP depletion reduced the ability of MDA-MB-231 cells to metastasize to the lung and the liver in an experimental metastasis model. We further demonstrated that TP depletion reduced the lung colonization ability of MDA-MB-231 cells by blocking active extravasation. Taken together, TP is expressed in breast cancer and that activation of TP has profound effects on tumor cell cytoskeleton and contraction through activation of RhoA. Inhibition or depletion of TP reduces the metastatic dissemination of breast cancer cells in vivo by blocking the extravasation of tumor cells. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2011 Nov 12-16; San Francisco, CA. Philadelphia (PA): AACR; Mol Cancer Ther 2011;10(11 Suppl):Abstract nr C45." @default.
- W2043931794 created "2016-06-24" @default.
- W2043931794 creator A5001222065 @default.
- W2043931794 creator A5076906855 @default.
- W2043931794 date "2011-11-12" @default.
- W2043931794 modified "2023-09-27" @default.
- W2043931794 title "Abstract C45: Validation of thromboxane A2receptor (TP) as a target to block breast cancer metastasis." @default.
- W2043931794 doi "https://doi.org/10.1158/1535-7163.targ-11-c45" @default.
- W2043931794 hasPublicationYear "2011" @default.
- W2043931794 type Work @default.
- W2043931794 sameAs 2043931794 @default.
- W2043931794 citedByCount "0" @default.
- W2043931794 crossrefType "proceedings-article" @default.
- W2043931794 hasAuthorship W2043931794A5001222065 @default.
- W2043931794 hasAuthorship W2043931794A5076906855 @default.
- W2043931794 hasConcept C121608353 @default.
- W2043931794 hasConcept C126322002 @default.
- W2043931794 hasConcept C134018914 @default.
- W2043931794 hasConcept C142724271 @default.
- W2043931794 hasConcept C170493617 @default.
- W2043931794 hasConcept C185592680 @default.
- W2043931794 hasConcept C2777093181 @default.
- W2043931794 hasConcept C2778938600 @default.
- W2043931794 hasConcept C2779013556 @default.
- W2043931794 hasConcept C2779540182 @default.
- W2043931794 hasConcept C2781024287 @default.
- W2043931794 hasConcept C502942594 @default.
- W2043931794 hasConcept C55493867 @default.
- W2043931794 hasConcept C62478195 @default.
- W2043931794 hasConcept C71924100 @default.
- W2043931794 hasConceptScore W2043931794C121608353 @default.
- W2043931794 hasConceptScore W2043931794C126322002 @default.
- W2043931794 hasConceptScore W2043931794C134018914 @default.
- W2043931794 hasConceptScore W2043931794C142724271 @default.
- W2043931794 hasConceptScore W2043931794C170493617 @default.
- W2043931794 hasConceptScore W2043931794C185592680 @default.
- W2043931794 hasConceptScore W2043931794C2777093181 @default.
- W2043931794 hasConceptScore W2043931794C2778938600 @default.
- W2043931794 hasConceptScore W2043931794C2779013556 @default.
- W2043931794 hasConceptScore W2043931794C2779540182 @default.
- W2043931794 hasConceptScore W2043931794C2781024287 @default.
- W2043931794 hasConceptScore W2043931794C502942594 @default.
- W2043931794 hasConceptScore W2043931794C55493867 @default.
- W2043931794 hasConceptScore W2043931794C62478195 @default.
- W2043931794 hasConceptScore W2043931794C71924100 @default.
- W2043931794 hasLocation W20439317941 @default.
- W2043931794 hasOpenAccess W2043931794 @default.
- W2043931794 hasPrimaryLocation W20439317941 @default.
- W2043931794 hasRelatedWork W1506574209 @default.
- W2043931794 hasRelatedWork W1558776379 @default.
- W2043931794 hasRelatedWork W1979471625 @default.
- W2043931794 hasRelatedWork W1994316362 @default.
- W2043931794 hasRelatedWork W2013120439 @default.
- W2043931794 hasRelatedWork W2026009684 @default.
- W2043931794 hasRelatedWork W2029397726 @default.
- W2043931794 hasRelatedWork W2053724485 @default.
- W2043931794 hasRelatedWork W2077346946 @default.
- W2043931794 hasRelatedWork W2088564822 @default.
- W2043931794 hasRelatedWork W2245627294 @default.
- W2043931794 hasRelatedWork W2321788886 @default.
- W2043931794 hasRelatedWork W2335681699 @default.
- W2043931794 hasRelatedWork W2368108450 @default.
- W2043931794 hasRelatedWork W2380736245 @default.
- W2043931794 hasRelatedWork W2405075276 @default.
- W2043931794 hasRelatedWork W2486662881 @default.
- W2043931794 hasRelatedWork W2562426181 @default.
- W2043931794 hasRelatedWork W2954134624 @default.
- W2043931794 hasRelatedWork W3132520529 @default.
- W2043931794 isParatext "false" @default.
- W2043931794 isRetracted "false" @default.
- W2043931794 magId "2043931794" @default.
- W2043931794 workType "article" @default.